您的位置: 首页 > 农业专利 > 详情页

NOVEL IN VITRO AND IN VIVO ENRICHMENT STRATEGY TARGETING LYMPHOCYTES DERIVED FROM VECTOR TRANSDUCED HSCS FOR THERAPY OF DISORDERS
专利权人:
THE MEDICAL COLLEGE OF WISCONSIN, INC;UNIVERSITY HEALTH NETWORK;WASHINGTON UNIVERSITY IN ST. LOUIS
发明人:
Jeffrey A. Medin,John F. Dipersio,Murtaza S. Nagree
申请号:
US16619883
公开号:
US20200181582A1
申请日:
2018.06.06
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention is related to a dual promoter lentiviral vector and methods of use for the treatment of diseases and disorders, specifically lysosomal storage disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充